ClinicalTrials.Veeva

Menu
H

Hattiesburg Clinic | Hematology/Oncology Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Pembrolizumab
Platinum
Dexamethasone
ABBV-400
MK-6482
Leucovorin
Cisplatin
Trifluridine
Bevacizumab
Fluorouracil

Parent organization

This site is a part of Hattiesburg Clinic

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 11 total trials

A Randomized Trial Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONSURF) Oral Tablets Plus IV Infused Bevacizumab in Adult Participants With c-Met Over-Expressed Refractory Metastatic Colorectal Cancer

Colorectal cancer (CRC) is the third most common type of cancer diagnosed worldwide and in China. The purpose of this study is to assess adverse even...

Enrolling
Metastatic Colorectal Cancer
Drug: ABBV-400
Drug: Trifluridine/Tipiracil

The primary objective of this study is to compare belzutifan to everolimus with respect to progression-free survival (PFS) per Response Evaluation Cr...

Active, not recruiting
Carcinoma, Renal Cell
Drug: Everolimus
Drug: Belzutifan

The current study will compare pembrolizumab (MK-3475) plus maintenance olaparib, vs. pembrolizumab plus maintenance olaparib placebo for the treatme...

Active, not recruiting
Carcinoma, Squamous Cell, Non-small-cell Lung
Drug: Olaparib
Drug: Paclitaxel

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess adverse events...

Enrolling
Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma
Esophageal Adenocarcinoma
Drug: Budigalimab
Drug: ABBV-400

Researchers are looking for new ways to treat people with head and neck cancer whose cancer has come back after treatment (recurrent) or whose cancer...

Active, not recruiting
Squamous Cell Carcinoma of Head and Neck
Drug: Cetuximab
Drug: Capecitabine

This is a randomized, multicenter, Phase 3, open-label study evaluating subcutaneous (SC) vs intravenous (IV) administration of isatuximab in combina...

Active, not recruiting
Plasma Cell Myeloma Recurrent
Drug: Montelukast
Drug: Dexamethasone

The current study will compare pembrolizumab (MK-3475) plus maintenance olaparib, versus (vs) pembrolizumab plus maintenance pemetrexed for the treat...

Active, not recruiting
Carcinoma, Nonsquamous Non-small-cell Lung
Drug: Carboplatin
Drug: Cisplatin

Chronic lymphocytic leukemia (CLL) is the most common leukemia (cancer of blood cells). The purpose of this study is to assess retreatment with venet...

Enrolling
Chronic Lymphocytic Leukemia (CLL)
Drug: Venetoclax
Drug: Obinutuzumab

Trial sponsors

Merck Sharp & Dohme (MSD) logo
AbbVie logo
Sanofi logo
Seagen logo
Yale University logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems